Nexalin Technology, Inc. (NASDAQ:NXL – Get Free Report) experienced a significant decrease in short interest during the month of May. As of May 31st, there were 60,600 shares sold short, a 16.9% decrease from the total on May 15th. This represents approximately 1.0% of the company’s shares being sold short. With an average daily trading volume of 544,300 shares, the short-interest ratio is currently 0.1 days.
The stock of Nexalin Technology opened at $0.90 on Friday, with a one-year low of $0.25 and a one-year high of $3.40. The company has a market capitalization of $6.69 million, a PE ratio of -1.36, and a beta of 5.13. The fifty-day moving average is $1.31, while the 200-day moving average is $0.80.
Nexalin Technology (NASDAQ:NXL – Get Free Report) recently reported its earnings results on Wednesday, March 27th. The company disclosed earnings per share (EPS) of ($0.10) for the quarter with revenue of $0.02 million. The company had a negative return on equity of 154.84% and a negative net margin of 3,088.12%.
Nexalin Technology, Inc. is a medical device company that designs and develops neurostimulation products for the treatment of mental health issues in the United States and China. The company is currently working on Generation 2 and Generation 3 products, which are in clinical trials for the treatment of substance abuse related to opiate, cocaine, alcohol abuse, Alzheimer’s disease, and dementia.
NASA’s Voyager 1, the most distant spacecraft from Earth, has resumed sending science data after…
The use of technology in schools has become a hot topic of discussion in Bend-La…
The TOI Sports Desk is highly skilled in various roles that involve capturing the excitement…
Grand Rapids, Michigan has implemented a new system using cameras, GPS, and computers to improve…
Manage consent settings on AMP pages are specific to Amplified Mobile Pages and may need…
The West End Health Foundation (WEHF) recently presented grants to schools in Ishpeming, Negaunee, and…